QUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISORDERS
申请人:Keseru Gyorgy
公开号:US20090270371A1
公开(公告)日:2009-10-29
Compounds of formula (I): and/or enantiomers and/or racemates and/or diastereomers and/or pharmaceutically acceptable salts thereof formed with acids or bases, to the process for their preparation, to the intermediates of the preparation process, to the pharmaceutical formulations containing these compounds and to their use in the prevention and/or treatment of mGluR5 receptor-mediated disorders.
公式(I)的化合物:及/或其对映体和/或外消旋体和/或非对映异构体和/或与酸或碱形成的药学上可接受的盐,其制备过程,制备过程中间体,包含这些化合物的制药配方以及它们在预防和/或治疗mGluR5受体介导的疾病中的用途。